zingerone has been researched along with Parkinson Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bubacco, L; Dedola, S; Delogu, G; Dettori, MA; Fabbri, D; Hussain, R; Mammi, S; Marchiani, A; Ruzza, P; Sanna, D; Serra, PA; Siligardi, G; Tessari, I | 1 |
| Bae, WY; Choi, JS; Jeong, JW; Park, C | 1 |
| Kabuto, H; Yamanushi, TT | 1 |
3 other study(ies) available for zingerone and Parkinson Disease
| Article | Year |
|---|---|
Small molecules interacting with α-synuclein: antiaggregating and cytoprotective properties.
Topics: Adrenal Gland Neoplasms; alpha-Synuclein; Alzheimer Disease; Animals; Antioxidants; Cell Line, Tumor; Curcumin; Cytoprotection; Guaiacol; Parkinson Disease; Pheochromocytoma; Rats; Styrenes | 2013 |
Zingerone activates VMAT2 during MPP(+) -induced Cell Death.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Death; Corpus Striatum; Disease Models, Animal; Dopaminergic Neurons; Drug Interactions; Guaiacol; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Neurotoxins; Parkinson Disease; Vesicular Monoamine Transport Proteins | 2015 |
Effects of zingerone [4-(4-hydroxy-3-methoxyphenyl)-2-butanone] and eugenol [2-methoxy-4-(2-propenyl)phenol] on the pathological progress in the 6-hydroxydopamine-induced Parkinson's disease mouse model.
Topics: Animals; Antioxidants; Ascorbic Acid; Catalase; Corpus Striatum; Disease Models, Animal; Dopamine; Eugenol; Free Radical Scavengers; Glutathione; Glutathione Peroxidase; Guaiacol; Levodopa; Male; Mice; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Superoxide Dismutase | 2011 |